CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-in Capital	Treasury Stock		Retained Earnings	Accumulated Other Comprehensive Income	Non- Controlling Interests
Balance, beginning of period (in shares) at Dec. 31, 2023			106,917,636
Balance, beginning of period at Dec. 31, 2023		$ 5,332,286	$ 1		$ 3,068,597	$ (1,265,097)		$ 3,510,544	$ 896	$ 17,345
Balance, beginning of period (in shares) at Dec. 31, 2023						54,211,879
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		642,547						640,856		1,691
Exercise of stock options and issuance of restricted stock units, net (shares)	[1]		791,084
Exercise of stock options and issuance of restricted stock units, net	[1]	$ (7,442)			(7,442)
Repurchase of common stock (shares)		4,238,767	4,238,767	[2]		4,238,767	[2]
Repurchase of common stock	[2]	$ (260,368)				$ (260,368)
Stock compensation expense		17,016			17,016
Distributions to non-controlling interests of consolidated joint ventures		(577)								(577)
Balance, end of period at Sep. 30, 2024		5,723,462	$ 1		3,078,171	$ (1,525,465)		4,151,400	896	18,459
Balance, end of period (in shares) at Sep. 30, 2024			103,469,953
Balance, end of period (in shares) at Sep. 30, 2024						58,450,646
Balance, beginning of period (in shares) at Jun. 30, 2024			104,425,808
Balance, beginning of period at Jun. 30, 2024		5,526,542	$ 1		3,070,721	$ (1,463,616)		3,900,274	896	18,266
Balance, beginning of period (in shares) at Jun. 30, 2024						57,407,167
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		251,472						251,126		346
Exercise of stock options and issuance of restricted stock units, net (shares)	[3]		87,624
Exercise of stock options and issuance of restricted stock units, net	[3]	$ 1,989			1,989
Repurchase of common stock (shares)		1,043,479	1,043,479	[4]		1,043,479	[4]
Repurchase of common stock	[4]	$ (61,849)				$ (61,849)
Stock compensation expense		5,461			5,461
Distributions to non-controlling interests of consolidated joint ventures		(153)								(153)
Balance, end of period at Sep. 30, 2024		5,723,462	$ 1		3,078,171	$ (1,525,465)		4,151,400	896	18,459
Balance, end of period (in shares) at Sep. 30, 2024			103,469,953
Balance, end of period (in shares) at Sep. 30, 2024						58,450,646
Balance, beginning of period (in shares) at Dec. 31, 2024			102,241,978
Balance, beginning of period at Dec. 31, 2024		5,878,180	$ 1		3,086,342	$ (1,616,170)		4,393,853	2,509	11,645
Balance, beginning of period (in shares) at Dec. 31, 2024						59,819,731
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		614,167						608,484		5,683
Exercise of stock options and issuance of restricted stock units, net (shares)	[5]		719,924
Exercise of stock options and issuance of restricted stock units, net	[5]	$ (936)			(936)
Repurchase of common stock (shares)		5,250,964	5,250,964	[6]		5,250,964	[6]
Repurchase of common stock	[6]	$ (312,291)				$ (312,291)
Stock compensation expense		22,337			22,337
Distributions to non-controlling interests of consolidated joint ventures		(3,458)								(3,458)
Changes in non-controlling interests of consolidated joint ventures		(484)								(484)
Balance, end of period at Sep. 30, 2025		6,197,515	$ 1		3,107,743	$ (1,928,461)		5,002,337	2,509	13,386
Balance, end of period (in shares) at Sep. 30, 2025			97,710,938
Balance, end of period (in shares) at Sep. 30, 2025						65,070,695
Balance, beginning of period (in shares) at Jun. 30, 2025			98,835,264
Balance, beginning of period at Jun. 30, 2025		6,057,862	$ 1		3,097,120	$ (1,853,266)		4,800,896	2,509	10,602
Balance, beginning of period (in shares) at Jun. 30, 2025						63,793,162
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		204,451						201,441		3,010
Exercise of stock options and issuance of restricted stock units, net (shares)	[7]		153,207
Exercise of stock options and issuance of restricted stock units, net	[7]	$ 4,087			4,087
Repurchase of common stock (shares)		1,277,533	1,277,533	[8]		1,277,533	[8]
Repurchase of common stock	[8]	$ (75,195)				$ (75,195)
Stock compensation expense		6,536			6,536
Changes in non-controlling interests of consolidated joint ventures		(226)								(226)
Balance, end of period at Sep. 30, 2025		$ 6,197,515	$ 1		$ 3,107,743	$ (1,928,461)		$ 5,002,337	$ 2,509	$ 13,386
Balance, end of period (in shares) at Sep. 30, 2025			97,710,938
Balance, end of period (in shares) at Sep. 30, 2025						65,070,695

[1] Dollar amount includes $7.5 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.

[2] Dollar amount includes an incremental amount related to the 1% excise tax on share repurchases.

[3] (1) Dollar amount includes $2.0 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units. (2) Dollar amount includes an incremental amount related to the 1% excise tax on share repurchases.

[4] Dollar amount includes an incremental amount related to the 1% excise tax on share repurchases.

[5] Dollar amount includes $10.0 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.

[6] Dollar amount includes an incremental amount related to the 1% excise tax on share repurchases.

[7] Dollar amount includes $4.1 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.

[8] Dollar amount includes an incremental amount related to the 1% excise tax on share repurchases.